Beijing Zhikangbo Medical Oncology Research

Beijing Zhikangbo Medical Oncology Research is a precision medicine company focused on providing personalized cancer treatment solutions through advanced functional diagnostic platforms. The company utilizes patient-derived cell (PDC), patient-derived organoid (PDO), and patient-derived xenograft (PDX) models to perform high-throughput drug sensitivity testing and biomarker discovery. By integrating clinical data with functional genomic insights, Zhikangbo aims to guide clinical decision-making and accelerate the development of novel oncology therapeutics. Their services cater to both clinical practitioners seeking optimized patient care and pharmaceutical partners looking for robust translational research platforms.